// App-Quantinova.ai

3301 : Breast cancer subtypes have distinct microbial and immune cytolytic transcriptomic signatures

Researchers

Presenter

  • Chandra Sekhar Pedamallu

Principal Investigators

  • Matthew Meyerson

  • Akinyemi Ojesina

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved